The engagement of FDG PET/CT image quality and harmonized quantification: from competitive to complementary Ronald Boellaard Editorial Commentary 01 October 2015 Pages: 1 - 4
Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients: from 223Ra-dichloride to new horizons for therapeutic response assessment Emilio BombardieriL. EvangelistaF. Boccardo Editorial 18 September 2015 Pages: 5 - 7
Factors affecting 223Ra therapy: clinical experience after 532 cycles from a single institution Elba C. EtchebehereDenái R. MiltonEric M. Rohren Original Article 29 September 2015 Pages: 8 - 20
Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting 223Ra-dichloride Massimiliano PacilioGuido VentroniLucio Mango Original Article 13 August 2015 Pages: 21 - 33
68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients Florian SterzingClemens KratochwilFrederik L. Giesel Original Article Open access 25 September 2015 Pages: 34 - 41
Dosimetry for 177Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer Andreas DelkerWolfgang Peter FendlerGuido Böning Original Article 29 August 2015 Pages: 42 - 51
Of standard of reference and accuracy: the problem of truth in imaging Stefano FantiElisabetta Lalumera Editorial Commentary 17 October 2015 Pages: 52 - 54
PET/CT with 11C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data Stefano FantiSilvia MinozziArturo Chiti Original Article 09 October 2015 Pages: 55 - 69
Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer Martin T. FreitagJan P. RadtkeAli Afshar-Oromieh Original Article 28 October 2015 Pages: 70 - 83
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel Francesco CeciPaolo CastellucciStefano Fanti Original Article 01 September 2015 Pages: 84 - 91
Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI Benedikt Michael SchaarschmidtPhilipp HeuschAxel Wetter Original Article 06 August 2015 Pages: 92 - 102
Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [18F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience Otto M. HenriksenVibeke A. LarsenIan Law Original Article 12 September 2015 Pages: 103 - 112
Imaging malignant melanoma with 18F-5-FPN Hongyan FengXiaotian XiaXiaoli Lan Original Article 11 August 2015 Pages: 113 - 122
Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series C. BrendleN. F. SchwenzerC. Schraml Original Article 31 July 2015 Pages: 123 - 132
Textural analysis of pre-therapeutic [18F]-FET-PET and its correlation with tumor grade and patient survival in high-grade gliomas Thomas PykaJens GemptStefan Förster Original Article 29 July 2015 Pages: 133 - 141
Amyloid imaging in cognitively normal older adults: comparison between 18F-flutemetamol and 11C-Pittsburgh compound B Katarzyna AdamczukJolien SchaeverbekeRik Vandenberghe Original Article 12 August 2015 Pages: 142 - 151
Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [11C]ABP688 PET Jonathan M. DuBoisOlivier G. RoussetEliane Kobayashi Original Article 21 August 2015 Pages: 152 - 162
Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [18F]DPA-714 PET Dieter OryAndrey PostnovCindy Casteels Original Article 01 September 2015 Pages: 163 - 172
Test–retest reproducibility of [11C]PBR28 binding to TSPO in healthy control subjects K. CollsteA. ForsbergS. Cervenka Original Article 22 August 2015 Pages: 173 - 183
Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease Soichiro ShimizuKentaro HiraoHaruo Hanyu Original Article Open access 02 August 2015 Pages: 184 - 192
Intense PSMA-expression using 68Ga-PSMA PET/CT in a paravertebral schwannoma mimicking prostate cancer metastasis Christoph RischplerTobias MaurerMatthias Eiber Image of the Month 27 October 2015 Pages: 193 - 194
Paget bone disease demonstrated on 68Ga-PSMA ligand PET/CT C. ArtigasJ. AlexiouP. Flamen Image of the Month 27 October 2015 Pages: 195 - 196
Patient’s weight: a neglected cause of variability in SUV measurements? A survey from an EARL accredited PET centre in 513 patients Charline LasnonBenjamin HouduNicolas Aide Letter to the Editor 17 October 2015 Pages: 197 - 199
Prostate-specific antigen and radiolabelled choline PET/CT for the assessment of response to therapy: synergy or conflicting? Laura EvangelistaEmilio Bombardieri Letter to the Editor 23 October 2015 Pages: 200 - 201
Erratum to: Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting Daniela PeraniChiara CeramiGiuseppe Magnani Erratum 08 October 2015 Pages: 202 - 203
Erratum to: Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis Georg KuhnertRonald BoellaardCarsten Kobe Erratum 19 October 2015 Pages: 204 - 205
Erratum to: Difficulties in deciding whether to ablate patients with putatively “low–intermediate-risk” differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study Savvas FrangosIoannis P. IakovouEvanthia I. Giannoula Erratum 02 November 2015 Pages: 206 - 207